BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2003
View Archived Issues
Dual adenosine A1/A2A antagonists and their use reported by Fujisawa
Read More
Novel VEGFR kinase inhibitors identified by Novartis researchers
Read More
Immunogenic peptides with utility in HIV infection therapy
Read More
Pharmacia scientists claim new alpha7 nAChR agonists in recent patent
Read More
New IKK inhibitors in early development at Roche
Read More
Amine salts of alphavbeta3 integrin antagonist covered by Merck patent
Read More
Wyeth presents new estrogenic agents with utility in osteoporosis, cancer, IBD, etc.
Read More
Fujisawa licenses carperitide in North America and Europe
Read More
Revimid demonstrates potential in myelodysplastic syndromes
Read More
ICN to make tender offer for outstanding shares of Ribapharm
Read More
Anika seeks FDA approval for Orthovisc
Read More
Nicotine increases muscle girth, decreases body weight and reduces appetite in mice
Read More
RxKinetix acquires exclusive rights to RK-0202
Read More
Grant supports development of virus cell-based assay for anti-HIV drug discovery
Read More
PDL initiates trial of anti-alpha5beta1 integrin antibody in solid tumors
Read More
Nuvion development targeted for ulcerative colitis
Read More
Oralin set to enter phase IIb shortly
Read More
Enrollment completed in Atrisone phase III studies
Read More
Baxter launches Aralast
Read More
Tricyclic quinoxalines as potential new agents for restenosis and cancer
Read More
Advexin able to stop progression of advanced esophageal cancer
Read More
AP-2238, the prototype of a novel class of AD therapeutics
Read More
Phase I clinical trial results for Bay-43-9006 summarized at ASCO
Read More
Phase I clinical evaluation initiated for HIV-based lentiviral vector from VIRxSYS
Read More
EMD-72000 shows good tolerability and evidence of antitumor activity in phase I trials
Read More